Ligand Pharmaceuticals Ownership | Who Owns Ligand Pharmaceuticals?

Overview Forecast RevenueFinancials Chart Transcripts

Ligand Pharmaceuticals Ownership Summary

Ligand Pharmaceuticals is owned by 188.03% institutional investors, 2.26% insiders. Tudor investment corp et al is the largest institutional shareholder, holding 81.78% of LGND shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 5.89% of its assets in Ligand Pharmaceuticals shares.

LGND Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Ligand Pharmaceuticals	188.03%	2.26%	-90.29%
Sector	Healthcare Stocks	42.54%	10.83%	46.63%
Industry	Biotech Stocks	45.22%	10.75%	44.04%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Tudor investment corp et al	15.75M	81.78%	$17.70M
Blackrock	2.87M	16.19%	$241.95M
Blackrock funding, inc. /de	2.88M	14.98%	$510.97M
Vanguard group	2.08M	10.78%	$367.79M
Janus henderson group	1.02M	5.51%	$108.76M
Macquarie group	751.79K	3.90%	$133.17M
State street	749.36K	3.89%	$132.74M
Congress asset management co /ma	667.31K	3.46%	$118.21M
Chicago capital	568.61K	2.95%	$100.72M
Stephens investment management group	554.54K	2.88%	$98.23M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Ashford capital management	244.43K	4.82%	$43.30M
Villere st denis j	279.95K	4.77%	$49.59M
Private capital management	227.16K	3.59%	$40.24M
Ranger investment management	275.34K	3.40%	$48.77M
Cardinal capital management llc /ct	133.67K	3.08%	$11.26M
Rice hall james & associates	294.49K	2.84%	$52.17M
Chicago capital	568.61K	2.48%	$100.72M
Essex investment management	61.14K	1.66%	$10.83M
Acuitas investments	402.49K	1.53%	$2.39M
Lisanti capital growth	29.68K	1.29%	$5.26M

Top Buyers

Holder	Shares	% Assets	Change
Tudor investment corp et al	15.75M	0.03%	15.75M
Fmr	457.23K	0.00%	431.01K
Acuitas investments	402.49K	1.53%	382.60K
Goldman sachs group	367.80K	0.01%	304.07K
Victory capital management	254.81K	0.03%	222.00K

Top Sellers

Holder	Shares	% Assets	Change
Cardinal capital management llc /ct	133.67K	3.08%	-425.56K
William blair investment management	-	-	-205.69K
Dimensional fund advisors lp	523.91K	0.02%	-180.61K
Macquarie group	751.79K	0.16%	-174.77K
Knott david m jr	-	-	-85.00K

New Positions

Holder	Shares	% Assets	Change	Value
Tudor investment corp et al	15.75M	0.03%	15.75M	$17.70M
Norges bank	46.29K	0.00%	46.29K	$4.96M
Trexquant investment lp	44.50K	0.08%	44.50K	$7.88M
Eam investors	30.18K	0.60%	30.18K	$5.26M
Moody aldrich partners	25.88K	0.87%	25.88K	$4.59M

Sold Out

Holder	Change
Mendota financial group	-1.00
Cgc financial services	-3.00
Tidemark	-4.00
Stephens consulting	-5.00
Voisard asset management group	-5.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2025	302	15.71%	36,213,424	92.32%	188	1.97%	163	15.60%	88	7.32%
Jun 30, 2025	266	2.31%	19,162,915	2.69%	99	1.05%	144	10.77%	82	-5.75%
Mar 31, 2025	258	-1.53%	18,645,944	2.31%	97	0.99%	128	-15.23%	88	46.67%
Dec 31, 2024	239	-2.85%	16,852,409	-6.71%	91	0.95%	135	-	57	7.55%
Sep 30, 2024	245	4.26%	18,062,996	4.71%	98	1.04%	135	9.76%	53	-26.39%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
iShares Core S&P Small-Cap ETF	1.15M	5.89%	-
Delaware Small Cap Core I	655.86K	3.59%	-57.44K
Macquarie Small Cap Core I	670.37K	3.44%	-14.18K
Janus Henderson US SMID Cap Growth MA	596.82K	3.09%	596.78K
Janus Henderson US SMID Cap Growth	596.82K	3.09%	-7.04K
Janus Henderson Triton D	596.82K	3.07%	-7.04K
Vanguard Total Stock Mkt Idx Inv	574.56K	2.96%	-12.07K
Vanguard US Total Market Shares ETF	529.85K	2.75%	-
iShares Russell 2000 ETF	461.37K	2.37%	-
Vanguard Small Cap Index	444.90K	2.29%	-2.72K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Dec 12, 2025	Espinoza Octavio	Chief Financial Officer	Sell	$339.71K
Dec 01, 2025	KOZARICH JOHN W	-	Sell	$34.86K
Dec 01, 2025	KOZARICH JOHN W	-	Sell	$9.20K
Dec 01, 2025	KOZARICH JOHN W	-	Sell	$17.83K
Dec 01, 2025	KOZARICH JOHN W	-	Sell	$785.38

Insider Transactions Trends

Date	Buy	Sell
2025 Q4	-	17
2025 Q3	-	8
2025 Q2	5	3
2025 Q1	-	1
2024 Q4	-	2

LGND Ownership FAQ

Who Owns Ligand Pharmaceuticals?

Ligand Pharmaceuticals shareholders are primarily institutional investors at 188.03%, followed by 2.26% insiders and -90.29% retail investors. The average institutional ownership in Ligand Pharmaceuticals's industry, Biotech Stocks , is 45.22%, which Ligand Pharmaceuticals exceeds.

Who owns the most shares of Ligand Pharmaceuticals?

Ligand Pharmaceuticals’s largest shareholders are Tudor investment corp et al (15.75M shares, 81.78%), Blackrock (2.87M shares, 16.19%), and Blackrock funding, inc. /de (2.88M shares, 14.98%). Together, they hold 112.95% of Ligand Pharmaceuticals’s total shares outstanding.

Does Blackrock own Ligand Pharmaceuticals?

Yes, BlackRock owns 16.19% of Ligand Pharmaceuticals, totaling 2.87M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 241.95M$. In the last quarter, BlackRock increased its holdings by 3.23K shares, a 0.11% change.

Who is Ligand Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Ashford capital management is Ligand Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 4.82% of its assets in 244.43K Ligand Pharmaceuticals shares, valued at 43.3M$.

Who is the top mutual fund holder of Ligand Pharmaceuticals shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of Ligand Pharmaceuticals shares, with 5.89% of its total shares outstanding invested in 1.15M Ligand Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools